We are live on
!
Find out more
Simplify Asset Management Portfolio holdings
AUM
$7.19B
Turnover
25.77%
1-Year Est. Return
6.88%
This Fund
S&P 500
This Quarter
Est. Return
+0.82%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$6.13B
AUM Growth
+$696M
(+13%)
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
18.61%
Top 10 Holdings %
Top 10 Hldgs %
92.45%
Holding
166
New
37
Increased
75
Reduced
18
Closed
24
Avg Time Held Equity + Options
0.9
years
Top 10 Avg Time Held Equity + Options
1.3
years
Top 20 Avg Time Held Equity + Options
0.9
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Simplify Government Money Market ETF
SBIL
|
+$1.05B |
| 2 |
UnitedHealth
UNH
|
+$23.9M |
| 3 |
Eli Lilly
LLY
|
+$17.5M |
| 4 |
Amgen
AMGN
|
+$16.6M |
| 5 |
Align Technology
ALGN
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Simplify Aggregate Bond ETF
AGGH
|
+$38.7M |
| 2 |
Simplify Multi-QIS Alternative ETF
QIS
|
+$15M |
| 3 |
Simplify Currency Strategy ETF
FOXY
|
+$9.3M |
| 4 |
Simplify Target 15 Distribution ETF
XV
|
+$9.29M |
| 5 |
Simplify Barrier Income ETF
SBAR
|
+$7.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.9% |
| 2 | Healthcare | 5.76% |
| 3 | Energy | 0.41% |
| 4 | Industrials | 0.31% |
| 5 | Technology | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Simplify Piper Sandler US Small-Cap PLUS Income ETF
LITL
$6.66M
| $2.7M | 0.04% |
91,464
| – | – |
2025 Q2
2 quarters
|
|
52
Thermo Fisher Scientific
TMO
$249B
| $2.68M | 0.04% |
4,619
+2,184
| +90% | +$1.24M |
2021 Q4
16 quarters
|
|
53
Abbott
ABT
$178B
| $2.67M | 0.04% |
21,330
+10,192
| +92% | +$1.3M |
2021 Q4
16 quarters
|
|
54
Delcath Systems
DCTH
$511M
| $2.64M | 0.04% |
261,126
| – | – |
2024 Q4
4 quarters
|
|
55
Abeona Therapeutics
ABEO
$249M
| $2.64M | 0.04% |
500,342
-64,667
| -11% | -$326K |
2024 Q2
6 quarters
|
|
56
argenx
ARGX
$51.5B
| $2.62M | 0.04% |
3,115
+1,456
| +88% | +$1.25M |
2024 Q2
6 quarters
|
|
57
Simplify US Equity PLUS Managed Futures Strategy ETF
CTAP
$165M
| $2.56M | 0.04% |
+100,000
| New | +$2.55M |
2025 Q4
0 quarters
|
|
58
HealthEquity
HQY
$7.43B
| $2.5M | 0.04% |
27,329
+11,524
| +73% | +$1.1M |
2025 Q3
1 quarter
|
|
59
Celldex Therapeutics
CLDX
$2.19B
| $2.31M | 0.04% |
85,000
| – | – |
2025 Q3
1 quarter
|
|
60
Abivax
ABVX
$7.68B
| $2.29M | 0.04% |
16,953
-44,496
| -72% | -$4.85M |
2025 Q3
1 quarter
|
|
61
Pacira BioSciences
PCRX
$1.45B
| $2.23M | 0.04% |
86,261
+41,315
| +92% | +$982K |
2024 Q4
4 quarters
|
|
62
Cypherpunk Technologies Inc
CYPH
$282M
| $2.17M | 0.04% |
1,872,322
+896,714
| +92% | +$980K |
2024 Q1
7 quarters
|
|
63
Benitec Biopharma
BNTC
$289M
| $2.04M | 0.03% |
151,163
+72,438
| +92% | +$1M |
2024 Q2
6 quarters
|
|
64
Compass Pathways
CMPS
$1.56B
| $2M | 0.03% |
290,000
| – | – |
2025 Q3
1 quarter
|
|
65
Oculis Holding
OCS
$442M
| $1.97M | 0.03% |
+98,765
| New | +$1.98M |
2025 Q4
0 quarters
|
|
66
MFA Financial
MFA
$662M
| $1.89M | 0.03% |
+202,500
| New | +$1.89M |
2025 Q4
0 quarters
|
|
67
Kyverna Therapeutics
KYTX
$351M
| $1.81M | 0.03% |
+192,339
| New | +$1.43M |
2025 Q4
0 quarters
|
|
68
Fulcrum Therapeutics
FULC
$280M
| $1.81M | 0.03% |
159,674
+76,440
| +92% | +$778K |
2023 Q1
11 quarters
|
|
69
Annaly Capital Management
NLY
$13.7B
| $1.78M | 0.03% |
79,655
+16,755
| +27% | +$365K |
2023 Q3
9 quarters
|
|
70
Palantir
PLTR
$483B
| $1.73M | 0.03% |
9,741
+1,288
| +15% | +$233K |
2025 Q3
1 quarter
|
|
71
Walmart Inc
WMT
$922B
| $1.73M | 0.03% |
15,494
+1,609
| +12% | +$173K |
2025 Q3
1 quarter
|
|
72
Edwards Lifesciences
EW
$49.8B
| $1.65M | 0.03% |
19,338
+9,284
| +92% | +$762K |
2024 Q4
4 quarters
|
|
73
Inventiva
IVA
$678M
| $1.57M | 0.03% |
+337,662
| New | +$1.57M |
2025 Q4
0 quarters
|
|
74
Cisco
CSCO
$448B
| $1.55M | 0.03% |
20,360
+3,969
| +24% | +$295K |
2025 Q3
1 quarter
|
|
75
Boston Scientific
BSX
$62.3B
| $1.48M | 0.02% |
15,551
+7,464
| +92% | +$732K |
2025 Q2
2 quarters
|
|
Similar funds
SAM
Simplify Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Simplify Asset Management held 166 positions worth $6.13B, up 13% from $5.43B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Simplify Asset Management deployed $1.14B of net new capital in Q4 2025, opening 37 new positions and adding to 75 existing holdings. Its largest new stake was Amgen: 52,350 shares worth $17.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 95% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Simplify Aggregate Bond ETF, an estimated $38.7M trimmed.
- Simplify Asset Management's largest Q4 2025 buy was Amgen: 52,350 shares worth $17.1M.
- Simplify Asset Management added most to Simplify Government Money Market ETF in Q4 2025, an estimated $1.05B increase.
- Simplify Asset Management's biggest Q4 2025 reduction was Simplify Aggregate Bond ETF, cutting an estimated $38.7M.
- Simplify Asset Management fully exited Simplify Currency Strategy ETF in Q4 2025, selling an estimated $9.3M.
- Simplify Asset Management's ten largest holdings make up 92% of its $6.13B portfolio in Q4 2025.
- Simplify Asset Management opened 37 new positions and closed 24 in Q4 2025.
- Simplify Asset Management's portfolio value rose 13% quarter-over-quarter to $6.13B.
Based on Simplify Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.